Skip to main content

Advertisement

ADVERTISEMENT

Videos

Use of Bromelain-based Enzymatic Debriding Agent in Wound Care

In this video, Dr. John C. Lantis II describes the use of a bromelain-based enzymatic debriding agent from a phase 2 trial presented at SAWC Spring 2023 in National Harbor, MD. The title of the poster presentation was "Results from a Phase 2 multicenter, randomized, placebo controlled, adaptive design study performed to evaluate safety and efficacy of Bromelain-based enzymatic debridement agent in debridement of Venous Leg Ulcers."

Advertisement

Advertisement

Advertisement